Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment (Q73086679)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2003

Language	Label	Description	Also known as
English	Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment	scientific article published on 01 May 2003

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Apostolia Maria Tsimberidou

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Tracey Waddelow

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Hagop M Kantarjian

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Maher Albitar

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Francis J Giles

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 May 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Leukemia Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

375-380

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Autocrine growth by two cytokines, interleukin-6 and tumor necrosis factor alpha, in the myeloma cell line KHM-1A.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An interleukin 1 like factor stimulates bone resorption in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept (Enbrel): update on therapeutic use

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900082-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0145-2126(02)00082-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73086679&oldid=1734151383"